Prof. Ener Cagri Dinleyici - Speaker at Microbiota events
Microbiotaevents chevron Speakers chevron Ener Cagri Dinleyici

Prof. Ener Cagri Dinleyici

Professor of Pediatrics at the Eskisehir Osmangazi University Faculty of Medicine, (Eskisehir, Turkey).

Ener Cagri Dinleyici is Professor of Pediatrics at the Eskisehir Osmangazi University Faculty of Medicine, Eskisehir, Turkey. His work focuses on microbiota, pediatric vaccine, pediatric infectious disease, pediatric intensive care. He is vice-president of the World Scientific Association of Probiotics Prebiotics in Pediatrics and member of numerous scientific societies.

  • Vice President, World Scientific Association of Probiotics Prebiotics in Pediatrics
  • Working Group Member, ESPGHAN, Committee of Nutrition, Special Interest Group Microbiota
  • Member of the European Society for Pediatric Infectious Diseases (ESPID)
  • Member of the European Society for Pediatric Intensive Care (ESPNIC)
  • Member of the European Meningococcal and Haemophilus Disease Society (EMGM)
  • Member of Turkish Society of Pediatric Infectious Disease
  • Member of Turkish Pediatric Intensive Care Society
  • Member of Pediatric Probiotic Prebiotic Functional Foods and Microbiota study

Ener Cagri Dinleyici is Professor of Pediatrics at the Eskisehir Osmangazi University Faculty of Medicine, Eskisehir, Turkey. His work focuses on microbiota, pediatric vaccine, pediatric infectious disease, pediatric intensive care. He is vice-president of the World Scientific Association of Probiotics Prebiotics in Pediatrics and member of numerous scientific societies.

  • Vice President, World Scientific Association of Probiotics Prebiotics in Pediatrics
  • Working Group Member, ESPGHAN, Committee of Nutrition, Special Interest Group Microbiota
  • Member of the European Society for Pediatric Infectious Diseases (ESPID)
  • Member of the European Society for Pediatric Intensive Care (ESPNIC)
  • Member of the European Meningococcal and Haemophilus Disease Society (EMGM)
  • Member of Turkish Society of Pediatric Infectious Disease
  • Member of Turkish Pediatric Intensive Care Society
  • Member of Pediatric Probiotic Prebiotic Functional Foods and Microbiota study
Why you should listen

After receiving his medical degree from the Istanbul University - Istanbul Faculty of Medicine in 1998, Ener Çagri Dinleyici completed his specialization in pediatrics at Eskişehir Osmangazi University between 1998 and 2003.

 

After research assistant in pediatrics, then assistant professor and associate professor, he is professor in pediatrics since 2014, at the same university. His work focuses on microbiome, pediatric vaccine preventable disease (especially meningococcal vaccines), pediatric infectious disease, pediatric intensive care.

 

He has been involved in organizing committees and scientific contact of international symposiums in Turkey and worldwide. He is, for example, the scientific organizer of three consecutive International Neonatal Maternal Immunization Symposium (INMIS) and founding member of the board of the INMIS platform. He organized the first International Congress of Pediatric Prebiotics and Probiotics in 2012 and was an organizing committee member of previous seven symposium.

 

Ener Cagri Dinleyici is the principal investigator of finalized or ongoing clinical trials about microbiome, pre/probiotics and vaccines and he has been involved phase clinical trials about vaccine and probiotics. He has authored or coauthored over 200 peer-reviewed articles and presented more than 500 in national and international symposiums.

He is the leading author in Turkey of PROBAGE study group, well-known for prospective randomized clinical trials about probiotics and microbiota field.

 

He is member of Global Meningococcal Initiative (GMI), European Pediatric Infectious Diseases Association (ESPID), European Pediatric Gastroenterology Hepatology Nutrition Association (ESPGHAN), European Society for Pediatric Intensive Care (ESPNIC), Turkish Pediatric Intensive Care Society. He is a board member of World Scientific Association of Prebiotic and Probiotic in Pediatric.

Key Studies

Yalcin SS. et al.
Intestinal mycobiota composition and changes in children with thalassemia who underwent allogeneic hematopoietic stem cell transplantation. Pediatr Blood Cancer. 2022 Jan;69(1):e29411.
https://pubmed.ncbi.nlm.nih.gov/34699120/

Dinleyici M. et al.
Human Milk Virome Analysis: Changing Pattern Regarding Mode of Delivery, Birth Weight, and Lactational Stage.
Nutrients. 2021 May 23;13(6):1779.
https://pubmed.ncbi.nlm.nih.gov/34071061/

Yasar Bilge NS. et al.
Intestinal microbiota composition of patients with Behçet's disease: differences between eye, mucocutaneous and vascular involvement. The Rheuma-BIOTA study.
Clin Exp Rheumatol. 2020 Sep-Oct;38 Suppl 127(5):60-68.
https://pubmed.ncbi.nlm.nih.gov/33124578/

Emre IE. et al.
The effect of probiotics on prevention of upper respiratory tract infections in the paediatric community - a systematic review.
Benef Microbes. 2020 May 11;11(3):201-211.
https://pubmed.ncbi.nlm.nih.gov/32314937/

Dinleyici M, Pérez-Brocal V. et al.
Human milk mycobiota composition: relationship with gestational age, delivery mode, and birth weight.
Benef Microbes. 2020 Mar 27;11(2):151-162.
https://pubmed.ncbi.nlm.nih.gov/31990220/

Ata B. et al.
The Endobiota Study: Comparison of Vaginal, Cervical and Gut Microbiota Between Women with Stage 3/4 Endometriosis and Healthy Controls.
Sci Rep. 2019 Feb 18;9(1):2204. doi: 10.1038/s41598-019-39700-6. https://pubmed.ncbi.nlm.nih.gov/30778155/

Dinleyici EC. et al.
Time Series Analysis of the Microbiota of Children Suffering From Acute Infectious Diarrhea and Their Recovery After Treatment. 
Front Microbiol. 2018 Jun 12;9:1230. 
https://pubmed.ncbi.nlm.nih.gov/29946306/ 
 

Yazar AS. et al.
Effects of zinc or synbiotic on the duration of diarrhea in children with acute infectious diarrhea. Turk J Gastroenterol. 2016 Nov;27(6):537-540. https://pubmed.ncbi.nlm.nih.gov/27852545/

Prof. Ener Cagri Dinleyici’s Microbiota Events

Wednesday, 7th September 2022
4:00pm - 4:25pm (CEST)

Antibiotics: short and long-term consequences in developing microbiota.